Growth Metrics

Electromed (ELMD) Liabilities and Shareholders Equity (2016 - 2025)

Electromed (ELMD) has disclosed Liabilities and Shareholders Equity for 15 consecutive years, with $54.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 5.04% to $54.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $214.8 million, a 6.15% increase, with the full-year FY2025 number at $53.8 million, up 3.0% from a year prior.
  • Liabilities and Shareholders Equity was $54.9 million for Q4 2025 at Electromed, up from $53.6 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $54.9 million in Q4 2025 to a low of $37.1 million in Q2 2021.
  • A 5-year average of $45.5 million and a median of $44.9 million in 2023 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: rose 14.15% in 2024, then grew 3.0% in 2025.
  • Electromed's Liabilities and Shareholders Equity stood at $38.2 million in 2021, then grew by 8.35% to $41.4 million in 2022, then increased by 13.46% to $47.0 million in 2023, then grew by 11.31% to $52.3 million in 2024, then grew by 5.04% to $54.9 million in 2025.
  • Per Business Quant, the three most recent readings for ELMD's Liabilities and Shareholders Equity are $54.9 million (Q4 2025), $53.6 million (Q3 2025), and $53.8 million (Q2 2025).